Artificial Intelligence-based Drug Development
Artificial Intelligence (AI)-based drug development is a revolutionary method used to accelerate the drug discovery process and the development of new treatments for various diseases. AI leverages data-driven techniques, such as computer-driven analysis of large data sets, to identify potential targets for drug discovery, find new drug combinations, and develop new medicines more effectively. By leveraging the power of AI, researchers can more quickly and accurately discover potential treatments and therapies, resulting in faster and more cost-effective medical breakthroughs. AI-driven drug development also has the potential to reduce the risks associated with traditional drug discovery, such as unintended side effects or toxicity. AI-based drug development is transforming the way drugs are discovered, developed and tested, leading to an overall improvement in drug efficacy and patient outcomes.
← Journal of Big Data Research